News: Cipla announced a INR 25 crore fund to support the Indian Government’s efforts to effectively combat the COVID-19 pandemic. This includes a voluntary donation of approximately INR 3 crore from Cipla employees who have stepped forward in this hour of national need. Through its wide-ranging relief efforts, the Company is focusing on initiatives that have the maximum impact and reach. It is currently supporting public health institutions, frontline healthcare workers, vulnerable patients and communities struggling in the aftermath.

News: Mumbai-based drug major Cipla, credited with several innovations especially in respiratory and flu therapy, could well become one of the first domestic companies to roll out new drugs for the coronavirus. The company is both fast-tracking development of these drugs with government laboratories, and repurposing its wide portfolio of respiratory, asthma, anti-virals and HIV drugs to meet challenges arising from Covid-19 in India.

Every year, through our #Breathefree initiative we reach out to over 2mn asthmatic patients, helping them to live a #BerokZindagi. We will continue our relentless pursuit until India breathes free.

#Asthma is a condition that needs to be managed properly with the help of an #inhaler. Watch as Radhika Apte, Chef Vikas Khanna, Parupalli Kashyap and Srishti tell you exactly why asthma ke liye #InhalersHainSahi.

Structural changes in the global pharma industry are throwing up challenges and opportunities. Enter Cipla with its expertise in medicine, and vision for relevance beyond pharma.